Life Stem Genetics Stock

Life Stem Genetics EV/FCF

EV/FCF (Enterprise Value to Free Cash Flow) of Life Stem Genetics (LIFS) as of Aug 16, 2026.

EV/FCF

0.00

Last updated:

EV/FCF (Enterprise Value to Free Cash Flow) of Life Stem Genetics is 2026 0.00 . EV/FCF (Enterprise Value to Free Cash Flow) of Life Stem Genetics was 2025 0.00 . It decreases by % lower compared to the previous year.
Access this data via the Eulerpool API

Life Stem Genetics Stock analysis

What does Life Stem Genetics do? Life Stem Genetics Inc is a company specializing in regenerative medicine, specifically in the manufacturing and application of stem cell therapies. It was founded in 2012 by experienced scientists and entrepreneurs and has since become a leading provider of stem cell treatments. The business model of Life Stem Genetics is based on the development and application of stem cell therapies that aim to regenerate diseased or injured tissues and organs. These therapies are utilized by specialized doctors and clinics worldwide to treat a variety of conditions and injuries, including degenerative diseases such as arthritis, osteoporosis, and Alzheimer's, as well as joint, muscle, and bone injuries. The company operates in various sectors, each focusing on different aspects of regenerative medicine. One of these sectors is the research of new stem cell therapies and technologies, aiming to improve the effectiveness and efficiency of treatments. This includes the identification of new types of stem cells, the development of new cultivation techniques, and the optimization of procedures for stem cell transplantation. Another sector of Life Stem Genetics is the production of stem cell products that can be used by doctors and clinics for patient treatment. This includes stem cell preparations for injection into the bloodstream or tissues, as well as freeze & thaw preparations used for long-term storage of stem cells. In addition to research and production of stem cell therapies, Life Stem Genetics also offers consulting services for doctors and clinics interested in utilizing stem cell treatments. This includes training and workshops on stem cell therapy, support in setting up stem cell clinics, and expert opinions on specific application areas. The products of Life Stem Genetics include various stem cell therapies tailored to the treatment of specific diseases and injuries. For example, the company offers stem cell therapies for the treatment of arthritis, spinal injuries, and diabetes. Furthermore, the company has also developed stem cell treatments specifically targeting the regeneration of skin tissue and hair follicles. Overall, Life Stem Genetics is an innovative company in the field of regenerative medicine, contributing to the improvement of patients' lives worldwide through its research, production, and application of stem cell therapies. With its diverse product portfolio and extensive expertise in the selection and use of stem cells, the company is a significant player in this field and will continue to play an important role in the development of new therapies and treatment options in the future. Life Stem Genetics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Life Stem Genetics stock

On Eulerpool you can find the complete historical development of EV/FCF (Enterprise Value to Free Cash Flow) Life Stem Genetics since 2006 – with annual values, charts, and detailed analysis.

The EV/FCF ratio measures the enterprise value relative to free cash flow. It captures the true cash-generating ability of a business.

To evaluate EV/FCF (Enterprise Value to Free Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/FCF (Enterprise Value to Free Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/FCF (Enterprise Value to Free Cash Flow)'s Life Stem Genetics with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Life Stem Genetics

All Key Metrics — Life Stem Genetics